Citigroup Inc Novartis Ag Transaction History

Citigroup Inc

$150 Billion
Q1 2024

A detailed history of Citigroup Inc transactions in Novartis Ag stock. As of the latest transaction made, Citigroup Inc holds 916,164 shares of NVS stock, worth $94.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

916,164

Previous 240,130 281.53%

Holding current value

$94.5 Million

Previous $24.2 Million 265.52%

% of portfolio

0.06%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$95.27 - $108.47 $64.4 Million - $73.3 Million	676,034 Added 281.53%	916,164 $88.6 Million
Q4 2023 Feb 09, 2024	BUY	$92.27 - $101.54 $5.11 Million - $5.63 Million	55,429 Added 30.01%	240,130 $24.2 Million
Q3 2023 Nov 09, 2023	BUY	$94.73 - $105.13 $68,679 - $76,219	725 Added 0.39%	184,701 $18.8 Million
Q2 2023 Aug 10, 2023	SELL	$92.52 - $104.91 $10.3 Million - $11.7 Million	-111,575 Reduced 37.75%	183,976 $18.6 Million
Q1 2023 May 11, 2023	BUY	$80.03 - $92.81 $9.52 Million - $11 Million	119,005 Added 67.41%	295,551 $27.2 Million

Q4 2022 Feb 09, 2023	BUY	$75.55 - $92.52 $635,753 - $778,555	8,415 Added 5.01%	176,546 $16 Million
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $105,946 - $123,909	1,420 Added 0.85%	168,131 $12.8 Million
Q2 2022 Aug 10, 2022	BUY	$80.52 - $93.75 $19,727 - $22,968	245 Added 0.15%	166,711 $14.1 Million
Q1 2022 May 12, 2022	BUY	$80.11 - $90.62 $1.02 Million - $1.15 Million	12,745 Added 8.29%	166,466 $14.6 Million
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $3.35 Million - $3.7 Million	-42,016 Reduced 21.47%	153,721 $13.4 Million
Q3 2021 Nov 10, 2021	BUY	$81.78 - $95.14 $16 Million - $18.6 Million	195,737 New	195,737 $16 Million

Others Institutions Holding NVS

# of Institutions

1,342

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account